Home>>Infectious Disease>> Bacterial Diseases>> Shigellosis>>Globotetraosylceramides (porcine RBC)

Globotetraosylceramides (porcine RBC) (Synonyms: Gb4Cers (porcine RBC), Globoside (porcine RBC), Globotetrahexosylceramide (porcine RBC))

Catalog No.GC43757

Globotetraosylceramides are bioactive neutral glycosphingolipids.

Products are for research use only. Not for human use. We do not sell to patients.

Globotetraosylceramides (porcine RBC) Chemical Structure

Cas No.: 11034-93-8

Size Price Stock Qty
5mg
$856.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Globotetraosylceramides are bioactive neutral glycosphingolipids. They are the major glycolipids in human erythrocytes. They act as receptors for the Shiga toxins Stx1, Stx2, and Stx2e, the cytotoxic protein pierisin-1, and parvovirus B19. Globotetraosylceramides increase the expression of proteins responsible for enamel deposition, including ameloblastin, amelogenin, and enamelin, in dental epithelial cells and activate the ERK and p38 MAPK signaling pathways. Levels of globotetraosylceramides are elevated in fibroblasts from patients with salt and pepper syndrome, a neurocutaneous condition characterized by intellectual disability and hyper- and hypo-pigmented skin. Globotetraosylceramides (porcine RBC) contains a mixture of globotetraosylceramides with variable fatty acyl chain lengths isolated from porcine red blood cells.

Reviews

Review for Globotetraosylceramides (porcine RBC)

Average Rating: 5 ★★★★★ (Based on Reviews and 11 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Globotetraosylceramides (porcine RBC)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.